OQS
NAUT icon

Occudo Quantitative Strategies’s Nautilus Biotechnolgy NAUT Stock Holding History

Occudo Quantitative Strategies’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-85,148
Closed -$523K – 1190
2021
Q3 		$523K Buy
+85,148
New +$678K 0.06% 524

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Occudo Quantitative Strategies's NAUT Position: Q4 2021 in Review

Occudo Quantitative Strategies sold out of Nautilus Biotechnolgy (NAUT) in Q4 2021, closing a stake of 85,148 shares — an estimated $523K sold.

Occudo Quantitative Strategies first reported a position in NAUT in Q3 2021 and held it in 1 quarter. The position peaked at $523K in Q3 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q4 2021.

  • Occudo Quantitative Strategies reported no remaining Nautilus Biotechnolgy position as of Q4 2021 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 85,148 Nautilus Biotechnolgy shares in Q4 2021, an estimated $523K.
  • Occudo Quantitative Strategies first reported a position in Nautilus Biotechnolgy in Q3 2021 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Nautilus Biotechnolgy position peaked at $523K in Q3 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2021.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.